EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.3.1.122 | Tuberculosis |
18992216 |
A coupled assay measuring Mycobacterium tuberculosis antigen 85C enzymatic activity. |
diagnostic usage
unassigned |
3
0 |
| 2.3.1.122 | Tuberculosis |
19356615 |
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. |
unassigned |
0 |
| 2.3.1.122 | Vaccinia |
19356615 |
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. |
unassigned |
0 |
| 2.3.1.122 | Tuberculosis |
15557632 |
A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. |
diagnostic usage
therapeutic application
unassigned |
3
1
0 |
| 2.3.1.122 | Infections |
25398087 |
A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 2.3.1.122 | Coinfection |
23369570 |
A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 2.3.1.122 | Influenza, Human |
23369570 |
A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 2.3.1.122 | Tuberculosis |
23369570 |
A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 2.3.1.122 | Tuberculosis |
22461526 |
A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1. |
therapeutic application
unassigned |
1
0 |
| 2.3.1.122 | Tuberculosis |
24980867 |
A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
